Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jouni Tuisku

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
EJNMMI Physics|March 10, 2016
Tissue probability-based AC for neurological PET/MR using SPM8Jarmo Teuho, Jani Linden, Jarkko Johansson, et al.
Brain Communications|January 7, 2022
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PETMarjo Nylund, Marcus Sucksdorff, Markus Matilainen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2019
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demiseGranville James Matheson, Pontus Plavén-Sigray, Jouni Tuisku, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Quantitative Evaluation of 2 Scatter-Correction Techniques for <sup>18</sup>F-FDG Brain PET/MRI in Regard to MR-Based Attenuation CorrectionJarmo Teuho, Virva Saunavaara, Tuula Tolvanen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 28, 2023
Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderlyLaura L Ekblad, Jouni Tuisku, Mikko Koivumäki, et al.
Parkinsonism & Related Disorders|July 22, 2023
Adenosine A<sub>2A</sub> receptor availability in cerebral gray and white matter of patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2014
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195Eero Rissanen, Jouni Tuisku, Johanna Rokka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple SclerosisMarcus Sucksdorff, Eero Rissanen, Jouni Tuisku, et al.
Journal of Neurology|September 2, 2022
Adenosine A<sub>2A</sub> receptor availability in patients with early- and moderate-stage Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Parkinsonism & Related Disorders|April 8, 2021
Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
EJNMMI Physics|March 10, 2016
Tissue probability-based AC for neurological PET/MR using SPM8Jarmo Teuho, Jani Linden, Jarkko Johansson, et al.
Brain Communications|January 7, 2022
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PETMarjo Nylund, Marcus Sucksdorff, Markus Matilainen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2019
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demiseGranville James Matheson, Pontus Plavén-Sigray, Jouni Tuisku, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Quantitative Evaluation of 2 Scatter-Correction Techniques for <sup>18</sup>F-FDG Brain PET/MRI in Regard to MR-Based Attenuation CorrectionJarmo Teuho, Virva Saunavaara, Tuula Tolvanen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 28, 2023
Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderlyLaura L Ekblad, Jouni Tuisku, Mikko Koivumäki, et al.
Parkinsonism & Related Disorders|July 22, 2023
Adenosine A<sub>2A</sub> receptor availability in cerebral gray and white matter of patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2014
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195Eero Rissanen, Jouni Tuisku, Johanna Rokka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple SclerosisMarcus Sucksdorff, Eero Rissanen, Jouni Tuisku, et al.
Journal of Neurology|September 2, 2022
Adenosine A<sub>2A</sub> receptor availability in patients with early- and moderate-stage Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Parkinsonism & Related Disorders|April 8, 2021
Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Pageof 5